Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.

Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Abstract Text:

    junko mitsuhashiJunko Mitsuhashi,satomi tsukaharaSatomi Tsukahara,rieko suzukiRieko Suzuki,yumiko oh-haraYumiko Oh-hara,saori nishiSaori Nishi,hiroyo hosoyamaHiroyo Hosoyama,kazuhiro katayamaKazuhiro Katayama,kohji noguchiKohji Noguchi,sayuri minowaSayuri Minowa,harumi shibataHarumi Shibata,yoshinori itoYoshinori Ito,kiyohiko hatakeKiyohiko Hatake,keisuke aibaKeisuke Aiba,shunji takahashiShunji Takahashi,yoshikazu sugimotoYoshikazu Sugimoto,junko mitsuhashiJunko Mitsuhashi,satomi tsukaharaSatomi Tsukahara,rieko suzukiRieko Suzuki,yumiko oh-haraYumiko Oh-hara,saori nishiSaori Nishi,hiroyo hosoyamaHiroyo Hosoyama,kazuhiro katayamaKazuhiro Katayama,kohji noguchiKohji Noguchi,sayuri minowaSayuri Minowa,harumi shibataHarumi Shibata,yoshinori itoYoshinori Ito,kiyohiko hatakeKiyohiko Hatake,keisuke aibaKeisuke Aiba,shunji takahashiShunji Takahashi,yoshikazu sugimotoYoshikazu Sugimoto,

    A clinical study of an MDR1 gene therapy protocol targeting metastatic breast cancer has been conducted in which the patients received high-dose chemotherapy, a transplant of MDR1-transduced autologous CD34(+) cells, and docetaxel. We herein report the molecular results of a 6-year follow-up of an individual in this study (patient 1). HaMDR-transduced cells, which had been initially detected in the peripheral blood of this individual, were found to have gradually decreased. After 10 cycles of docetaxel (days 71-316), MDR1 transgene levels were found to have increased, and then decreased to undetectable levels by day 1461. Thirty-eight MDR1-transduced clones were identified in patient 1, of which 11 showed a retroviral integration in close proximity to genes listed in the Retrovirus Tagged Cancer Gene Database (RTCGD). Four short-life clones in this group were found to harbor retroviral integrations close to the ZFHX1B, NOTCH1, BMI1, or HHEX gene; these genes have been frequently reported in the RTCGD. In addition, a long-lived RTCGD-hit clone, L-34, had a retroviral integration at a position 179 kb upstream of the EVI1 gene. L-34 was detectable on days 327-1154, but became undetectable 3 years after the docetaxel treatments had ceased. An additional three docetaxel-induced long-life clones showed comparable polymerase chain reaction profiles, which were also similar to that of the total MDR1-transduced cells. Our results thus show that docetaxel may have been effective in promoting the expansion of several MDR1-transduced clones in patient 1, but that they persist in the peripheral blood for only a few years.

    Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Publishing Authors By Initials

    j mitsuhashiJ Mitsuhashi,s tsukaharaS Tsukahara,r suzukiR Suzuki,y oh-haraY Oh-hara,s nishiS Nishi,h hosoyamaH Hosoyama,k katayamaK Katayama,k noguchiK Noguchi,s minowaS Minowa,h shibataH Shibata,y itoY Ito,k hatakeK Hatake,k aibaK Aiba,s takahashiS Takahashi,y sugimotoY Sugimoto,j mitsuhashiJ Mitsuhashi,s tsukaharaS Tsukahara,r suzukiR Suzuki,y oh-haraY Oh-hara,s nishiS Nishi,h hosoyamaH Hosoyama,k katayamaK Katayama,k noguchiK Noguchi,s minowaS Minowa,h shibataH Shibata,y itoY Ito,k hatakeK Hatake,k aibaK Aiba,s takahashiS Takahashi,y sugimotoY Sugimoto,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Human gene therapy

    VOLUME: 18

    Page Numbers: 895-906

    Journal Abbreviation: Hum. Gene Ther.

    ISSN: 1043-0342

    DAY: 17

    MONTH: Oct

    YEAR: 2007

    Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9008950

    Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.

    AFFILIATION: Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hum Gene Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News